Reborna Biosciences
Developer of a drug discovery technology designed to demonstrate fundamental treatment effects through the normalization of RNA function. The company's technology creates small-molecule drugs with an ...
Valuation
$15.2M
Market implied
Share Price
N/A
Total Raised
$18.5M
Last Round
N/A